# task306_qwen_aime_v11_30b_task301_same_harness_aime_eval_s1 - history log

<!-- METADATA:SESSION=1 -->

## Session 88 - 2026-06-02 UTC - assignment

- Created by `intern_nemotron_lead` after #367/task304 merged and worker_3
  final closeout mailbox `eb40f945d1134bb2be2fa8f82cb8b93a` was processed.
- Assigned to `intern_nemotron_worker_3`.
- Purpose: corrected AIME2025 same-harness FT-vs-base comparison for task301
  Qwen3-30B-A3B salvage checkpoint `iter_0000035`.
- Current main: `7a93a6cea16e45284a58287b91c0069b7416fa99`.
- Accepted base comparator: task300 Qwen3-30B-A3B base `15/30 = 0.5` with
  artifact root
  `/work-agents/intern_nemotron_worker_3/outputs/task300_qwen_aime_v11_30b_same_harness_testing_s1/run_20260602T152008Z`.
- Required disposition: PASS only if FT corrected AIME exact-normalized score
  is `>= 15/30`; FAIL if below base; HOLD if same-harness proof or artifacts
  are incomplete; BLOCK if boundaries would be violated.
- Boundaries: no training, no AIME2025 train prompts/labels, no task255 reuse,
  no shared deletion, no promotion, no production endpoint, no direct main
  push/merge, and no export/endpoint unless the worker stops and reports a
  lead-authorized eval-only need.

## Session 1 - 2026-06-02 UTC - accepted by worker

- Accepted by `intern_nemotron_worker_3` on branch
  `intern_nemotron_worker_3/task306_qwen_aime_v11_30b_task301_same_harness_aime_eval_s1`
  from `origin/main` `7a93a6cea16e45284a58287b91c0069b7416fa99`.
- Imported task docs from
  `origin/intern_nemotron_lead/session1-recovery-task-docs`
  `a9c380e97f9d05fa3dc05a6f4977bbe7f3ce270a`.
- Initial plan: prove or fail same-harness equivalence against task300, prefer
  the no-export/no-endpoint task304 MCore route for task301 `iter_0000035`,
  and run or precisely block corrected AIME2025 FT-vs-base evaluation.
- Boundaries reaffirmed: no training/optimizer, no AIME train data, no task255,
  no shared deletion, no promotion, no production endpoint, no main push, no
  merge/self-merge, and no export/endpoint unless stopped for lead
  authorization.
